Maat Pharma SA (MAAT) — Strategic Asset Allocation Index
Maat Pharma SA (MAAT) has a Strategic Asset Allocation Index of 83.2% as of December 2024. Strategic assets (PP&E of €8.60 Million plus long-term investments of €-) total €8.60 Million, measured against net assets of €10.34 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Maat Pharma SA Strategic Asset Allocation Index (2017–2024)
This chart shows how Maat Pharma SA's Strategic Asset Allocation Index has evolved across 7 annual periods from 2017 to 2024. As of December 2024, the index stands at 83.2%, representing strategic assets of €8.60 Million against net assets of €10.34 Million EUR. Explore how efficiently does Maat Pharma SA generate cash to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Maat Pharma SA (2017–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Maat Pharma SA from 2017 to 2024, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Maat Pharma SA market cap and net worth.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 83.2% | €8.60 Million | €8.60 Million | €- | €10.34 Million | ▲ +38.4 pp |
| 2023 | 44.8% | €9.17 Million | €9.17 Million | €- | €20.47 Million | ▲ +41.2 pp |
| 2022 | 3.6% | €966.00K | €966.00K | €- | €26.81 Million | ▲ +0.8 pp |
| 2021 | 2.8% | €1.11 Million | €1.11 Million | €- | €39.86 Million | ▼ -4.1 pp |
| 2020 | 6.9% | €1.10 Million | €1.10 Million | €- | €15.94 Million | ▼ -23.9 pp |
| 2018 | 30.8% | €391.00K | €391.00K | €- | €1.27 Million | ▲ +24.9 pp |
| 2017 | 5.9% | €312.95K | €312.95K | €- | €5.27 Million | — |